Carlos Naranjo-Galvis

7PUBLICATIONS
20CO-AUTHORS
Innate immunityEpigenetics (incl. genome methylation and epigenomics)Optical technologyCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 30, 2026
Host Immunogenetic Profile Modulates Susceptibility to Apical Periodontitis in a Colombian Population.

Ingrid Giraldo-Quiceno, Natalia Andrea Torres-Calvo, Andrés Felipe Ayala-Jaramillo

|Jan 21, 2026
CXCL1, RANTES, IFN-γ, and TMAO as Differential Biomarkers Associated with Cognitive Change After an Anti-Inflammatory Diet in Children with ASD and Neurotypical Peers.

Luisa Fernanda Méndez-Ramírez, Miguel Andrés Meñaca-Puentes, Luisa Matilde Salamanca-Duque

|Sep 27, 2025
Metagenomic Characterization of Gut Microbiota in Children with Autism Spectrum Disorder: Microbial Signatures and Modulation by Anti-Inflammatory Diet and Probiotics.

Marysol Valencia-Buitrago, Rodrigo Dias Oliveira-Carvalho, Valbert Cardoso

|Aug 28, 2025
Anti-Inflammatory Diet and Probiotic Supplementation as Strategies to Modulate Immune Dysregulation in Autism Spectrum Disorder.

Carlos Andrés Naranjo-Galvis, Diana María Trejos-Gallego, Cristina Correa-Salazar

|Oct 28, 2023
Genetic Variations in the Purinergic P2X7 Receptor Are Associated with the Immune Response to Ocular Toxoplasmosis in Colombia.

Carlos A Naranjo-Galvis, Rima McLeod, Jorge Enrique Gómez-Marín

|May 29, 2019
Publisher Correction: Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.

Huân M Ngô, Ying Zhou, Hernan Lorenzi

Pageof 2